XSHE
000553
Market cap1.86bUSD
Jul 10, Last price
5.77CNY
1D
-0.35%
1Q
-9.28%
Jan 2017
-61.56%
Name
ADAMA Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ADAMA Ltd., along with its affiliated companies, operates primarily in the agricultural sector as a crop protection enterprise. Its operations are divided into two key segments: Crop Protection (Agro), and Intermediates and Ingredients. Within its Crop Protection division, ADAMA develops, manufactures, and markets essential products such as herbicides, insecticides, and fungicides. These are designed to assist farmers in safeguarding their crops against threats like weeds, insects, and plant diseases. The Intermediates and Ingredients segment supplies a diverse range of chemical compounds, including various food additives, Lycopan (an anti-oxidation agent), synthetic aromatic substances, dietary supplements, food colorants, and components for enhancing texture and flavor. It also provides ingredients for food fortification and other specialized chemicals. Beyond these core offerings, the company manufactures fragrance products utilized across the perfume, cosmetics, body care, and detergent industries. It also delivers industrial goods, formulations, flame retardants, non-agricultural items, and comprehensive consumer and professional solutions. ADAMA maintains a significant global presence, conducting business across Europe, North America, Latin America, the Asia Pacific region, India, the Middle East, and Africa. The company, established in 1945 and headquartered in Jingzhou, Hubei, was formerly known as Hubei Sanonda Co., Ltd. It adopted its current name, ADAMA Ltd., in December 2018 and operates as a subsidiary of Syngenta Group Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||